Company Overview of KAEL-GemVax Co., Ltd.
KAEL-GemVax Co., Ltd. develops cancer vaccines and anti-inflammation drugs. Its products include GV1001, an epitope vaccine to ensure that the immune system encounters a sufficient number of the epitopes against which an immune response is desired, and encounters them in the right way for the desired immune response to actually begin; and novel peptide-based anti-inflammatory therapeutic drugs to provide cures for various inflammatory diseases. KAEL-GemVax Co., Ltd. was formerly known as GemVax Co., Ltd. The company was founded in 2001 and is based in Seongam-si, South Korea. KAEL-GemVax Co., Ltd. operates as a subsidiary of GemVax & Kael Co., Ltd.
3rd Floor GemVax Tower
Founded in 2001
82 2 544 6221
82 2 3443 4997
Key Executives for KAEL-GemVax Co., Ltd.
Similar Private Companies By Industry
|Lilly Korea Ltd.||Asia|
|Won Gwang Bio||Asia|
|Choongwae Shin-Yak Corporation||Asia|
|Alvogen Korea Ltd.||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact KAEL-GemVax Co., Ltd., please visit www.kaelgemvax.com. Company data is provided by Capital IQ. Please use this form to report any data issues.